-
Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A. Haemophilia. 2023 Sep; 29(5):1234-1242.
Young G, Callaghan MU, Balasa V, Soni A, Ahuja S, Roberts JC, Simpson ML, Kizilocak H, Frick A, Mokdad AG, Xing S, Caicedo J. PMID: 37553998.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Treatment of Congenital Afibrinogenemia in a Neonate With Critical Pulmonary Stenosis. J Pediatr Pharmacol Ther. 2023; 28(3):268-271.
Parikh P, Diep K, Balasa V, Lucas TL. PMID: 37303762; PMCID: PMC10249975.
View in:
PubMed Mentions:
-
SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature. J Pediatr Hematol Oncol. 2023 03 01; 45(2):82-87.
Calderwood S, Sabir A, Rao L, Baker B, Balasa V, Sathi BK. PMID: 36162052.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A. Expert Rev Hematol. 2022 10; 15(10):943-950.
Sun SX, Frick A, Balasa V, Roberts JC. PMID: 36000620.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study. Acta Haematol. 2022; 145(2):160-169.
Sathi BK, Yoshida Y, Weaver MR, Nolan LS, Gruner B, Balasa V, Altes T, Leiva-Salinas C. PMID: 34749363; PMCID: PMC9116597.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A. J Med Econ. 2020 Dec; 23(12):1493-1498.
Graf L, Yan S, Shen MC, Balasa V. PMID: 32969738.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup. Clin Pharmacokinet. 2020 02; 59(2):245-256.
Chelle P, Yeung CHT, Croteau SE, Lissick J, Balasa V, Ashburner C, Park YS, Bonanad S, Megías-Vericat JE, Nagao A, Wynn T, Corrales-Medina F, Tran H, Sharathkumar A, Chitlur M, Sarmiento S, Edginton A, Iorio A. PMID: 31435896.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Switching patients in the age of long-acting recombinant products? Expert Rev Hematol. 2019; 12(sup1):1-13.
Escobar M, Santagostino E, Mancuso ME, Coppens M, Balasa V, Taylor JA, Iorio A, Negrier C. PMID: 31282771.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Transfusion practices and complications in thalassemia. Transfusion. 2018 12; 58(12):2826-2835.
Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP. PMID: 30260477.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCTClinical Trials
-
Case 1: raccoon eyes in an 8-month-old infant. Case 2: jaundice in a teenage girl. Case 3: extreme muscle weakness in a 10-year-old boy. Pediatr Rev. 2014 Apr; 35(4):169-74.
Bavle A, Balasa VV, Chan K, El-Kadri A, Ng V, Torchinsky MY. PMID: 24692157.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion. 2008 Sep; 48(9):1971-80.
Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP, Multi-Center Iron Overload Research Group. PMID: 18513257; PMCID: PMC4613769.
View in:
PubMed Mentions:
14 Fields:
Translation:
Humans
-
New anticoagulants: a pediatric perspective. Pediatr Blood Cancer. 2005 Nov; 45(6):741-52.
Balasa VV. PMID: 15782418.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am. 2004 Dec; 86(12):2642-7.
Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, Mehlman CT, Crawford AH. PMID: 15590848.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003 May; 25(5):379-86.
Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ, Pediatric Coagulation Consortium. PMID: 12759624.
View in:
PubMed Mentions:
31 Fields:
Translation:
HumansCTClinical Trials
-
Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol. 2002 Jun-Jul; 24(5):374-9.
Balasa VV, Kalinyak KA, Bean JA, Stroop D, Gruppo RA. PMID: 12142786.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke. J Pediatr. 2000 Nov; 137(5):714-8.
Gruppo R, Degrauw A, Fogelson H, Glauser T, Balasa V, Gartside P. PMID: 11060540.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):397-400.
Balasa VV, Gruppo RA, Gartside PS, Kalinyak KA. PMID: 10524453.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999 May; 81(5):739-44.
Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, Wang P. PMID: 10365747.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans